Dr Matthew Joseph Kist, AUD | |
463 Erlanger Rd, Erlanger, KY 41018-1427 | |
(859) 342-5846 | |
(859) 342-4979 |
Full Name | Dr Matthew Joseph Kist |
---|---|
Gender | Male |
Speciality | Qualified Audiologist |
Experience | 5 Years |
Location | 463 Erlanger Rd, Erlanger, Kentucky |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1861049629 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
231H00000X | Audiologist | A.02221 (Ohio) | Secondary |
231H00000X | Audiologist | 247998 (Kentucky) | Primary |
Provider Name | Northern Kentucky Audiology |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1083295323 PECOS PAC ID: 8224436746 Enrollment ID: O20211013001076 |
News Archive
"The Millennium Challenge Corporation (MCC), through its partnership with the Millennium Challenge Account-Lesotho, is helping Lesotho address key challenges in its health sector through a $122 million investment in health infrastructure and health systems," IIP Digital reports.
On April 28, the Center for BrainHealth will bring together national experts to discuss solutions to our most pressing brain-related challenges at its inaugural Brain Health Summit, titled "The Human Brain: Resilience and Regeneration."
Ocular Therapeutix, Inc. announces the start of its Phase 3 clinical program to evaluate the safety and efficacy of their sustained release dexamethasone, an ophthalmic corticosteroid for the treatment of post-operative inflammation and pain following cataract surgery. Ocular Therapeutix's dexamethasone is administered as a one-time, bioabsorbable intracanalicular plug for release of the steroid to the ocular surface for up 30 days.
Patients infected with the hepatitis C virus (HCV) are six times as likely to develop non-Hodgkin's lymphoma (NHL) than individuals that are virus free, according to research presented at the Third Annual Frontiers in Cancer Prevention Research meeting.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Matthew Joseph Kist, AUD 463 Erlanger Rd, Erlanger, KY 41018-1427 Ph: (859) 342-5846 | Dr Matthew Joseph Kist, AUD 463 Erlanger Rd, Erlanger, KY 41018-1427 Ph: (859) 342-5846 |
News Archive
"The Millennium Challenge Corporation (MCC), through its partnership with the Millennium Challenge Account-Lesotho, is helping Lesotho address key challenges in its health sector through a $122 million investment in health infrastructure and health systems," IIP Digital reports.
On April 28, the Center for BrainHealth will bring together national experts to discuss solutions to our most pressing brain-related challenges at its inaugural Brain Health Summit, titled "The Human Brain: Resilience and Regeneration."
Ocular Therapeutix, Inc. announces the start of its Phase 3 clinical program to evaluate the safety and efficacy of their sustained release dexamethasone, an ophthalmic corticosteroid for the treatment of post-operative inflammation and pain following cataract surgery. Ocular Therapeutix's dexamethasone is administered as a one-time, bioabsorbable intracanalicular plug for release of the steroid to the ocular surface for up 30 days.
Patients infected with the hepatitis C virus (HCV) are six times as likely to develop non-Hodgkin's lymphoma (NHL) than individuals that are virus free, according to research presented at the Third Annual Frontiers in Cancer Prevention Research meeting.
› Verified 4 days ago
Northern Kentucky Audiology Audiologist Medicare: Medicare Enrolled Practice Location: 463 Erlanger Rd, Erlanger, KY 41018 Phone: 859-342-5846 | |
Luhn Hearing Care Llc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 463 Erlanger Rd, Erlanger, KY 41018 Phone: 859-342-5846 Fax: 859-342-4979 |